Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1341-1345

  Bodner, Klaus ^a,b   Laubichler, Peter ^a   Kimberger, Oliver ^a   Czerwenka, Klaus ^a   Zeillinger, Robert ^a   Bodner Adler, Barbara ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c AL AIN HOSPITAL   (United Arab Emirates)

Author keywords

Adeno carcinoma; Oestrogen receptors; Progesterone receptors; Uterine cervix

Indexed keywords

CARBOPLATIN; ESTROGEN RECEPTOR; PACLITAXEL; PROGESTERONE RECEPTOR;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME; UTERINE CERVIX ADENOCARCINOMA; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; ADULT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77953787186     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Baalbergen A, Ewing-Graham PC, Hop WCJ, Striujk P and Heimerhorst TH: Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 92: 262-267, 2004.
2. Chen RJ, Chang DY, Yen ML, Fung Lee E, Huang SC, Chow SN and Hsieh CY: Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 69: 157-164, 1998.
3. Ishikawa H, Nakanishi T, Inoue T and Kuzuya K: Prognostic factors of adenocarcinoma of the uterine cervix. Gynecol Oncol 73: 42-46, 1999.
4. Kauppilla A, Kujansuu E and Vihko R: Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy and progestin. Clinical correlates. Cancer 20: 2157-2162, 1982.
5. Osborne CK, Yochmowitz MG, Knight WA and Mc Giure WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888, 1980.
6. Cano A, Serra V, Rivera J, Monmeneu R and Marzo C: Expression of estrogen receptors, progesterone receptors and an estrogen-receptor associated protein in the human cervix during menstrual cycle and menopause. Fertil Steril 54: 1058-1064, 1990.
7. Nonogaki H, Fujii S, Konishi I, Nanbu Y, Ozaki S, Ishikawa Y and Mori T: Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix. Cancer 66: 2620-2627, 1990.
8. Wakefield EA and Wells M: Histochemical study of endocervical glycoproteins throughout the normal menstrual cycle and adjacent to cervical intraepithelial neoplasia. Int J Gynecol Pathol 4: 230-239, 1985.
9. Fujiwara H, Tortolero-Luna G, Follen Mitchel M, Koulos JP and Wright TC: Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer 79(3): 505-511, 1997.
10. Masood S, Rhatigan RM, Wilkinson EW, Barwick KW and Wilson WJ: Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunohistochemical study. Cancer 72: 511-518, 1993.
11. Ghandour FA, Atanoos R, Nahar K, Gee JW, Bigrigg A and Ismail SM: Immuncytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the uterine cervix. Histopathology 24: 49-55, 1994. (Pubitemid 24223139)
12. Suzuki Y, Nakano T, Arai T, Morita S, Tsujii H and Oka K: Progesterone receptor is a favourable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix. Int J Radiation Oncoloy Biol Phys 47(5): 1229-1234, 2000.
13. Kim JW, Sung HR, Kim DK and Song CH: Estrogen and progesterone receptor assay in carcinoma of the cervix with monoclonal antibodies. Gynecol Oncol 47: 306-310, 1992.
14. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. Am J Stat Assoc 53: 457-481, 1958.
15. Kupryjanczyk J and Miller P: Estrogen receptor distribution in the normal and pathologically changed human cervix uteri: an immunhistochemical study with the uses of monoclonal anti-ER antibody. Int J Gynecol Pathol 1: 75-85, 1988. (Pubitemid 18070450)
16. Hunter RE, Longcope C and Keough P: Steroid hormone receptors in carcinoma of the cervix. Cancer 69: 392-396, 1992.
17. Potish RA, Twiggs LB, Adock LL, Prem KA, Savage JE and Leung BS: Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervix. Cancer 58: 1709-1713, 1986.
18. Scambia G, Panici PB, Battaglia F, Ferrandina G, Greggi S and Mancuso S: Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen. Gynecol Oncol 37: 323-326, 1990.
19. Martin JD, Hahnel R, Mc Cartney AJ and De Klerk M: The influence of estrogen and progesterone receptors on survival in patients with carcinoma of the uterine cervix. Gynecol Oncol 23: 329-335, 1986.
20. Gao YL, Twiggs LB, Leung BS, Yu WCY, Potish RA, Okagaki T, Adeock LL and Prem KA: Cytoplasmatic estrogen and progesterone receptors in primary cervical adenocarcinoma: clinical and histopathological correlates. Am J Obstet Gynecol 146: 299-306, 1983.